Beta Amyloid Toxicity
Beta Amyloid Toxicity - Related Videos
01:25
Beta
0 Views •
2024
Beta is a crucial metric in finance used to assess an investment's risk and expected return relative to the overall market. It is calculated as the slope of the line in a scatterplot that compares the returns of an individual stock to the returns of the market benchmark, typically represented by a broad market index. Beta quantifies how much a stock's price moves in response to market movements, providing insight into its volatility and systematic risk. A beta of one indicates that the stock's...
13:59
Assaying β-amyloid Toxicity using a Transgenic C. elegans Model
0 Views •
Cited by 76 •
2010
The intensely studied nematode worm Caenorhabditis elegans can be transgenically engineered to express the human β-amyloid peptide (Aβ). Induced expression of Aβ in C. elegans muscle leads to a rapid, reproducible paralysis phenotype that can be used to monitor treatments that modulate Aβ toxicity.
08:16
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
0 Views •
Cited by 41 •
2015
Here, we present a protocol for direct stereotaxic brain infusion of amyloid-beta. This methodology provides an alternative in vivo mouse model to address the short-term effects of amyloid-beta on brain neurons.
04:53
Establishing an Alzheimer's Disease Rat Model Through an Amyloid-Beta Peptide Injection
0 Views •
2025
This video demonstrates the procedure for injecting amyloid-beta peptides, aluminum chloride, and a neuroinflammatory growth factor, which collectively aids in toxic amyloid plaque formation in the hippocampus region. This causes memory impairment in the rat, characteristic of Alzheimer's disease.
09:50
In situ Quantification of Pancreatic Beta-cell Mass in Mice
0 Views •
Cited by 6 •
2010
The following protocol outlines the process of pancreatic dissection for virtual slice imaging, and the subsequent quantification of all GFP-tagged beta-cells in the entire pancreas.
FAQs
Soluble oligomers can associate with neuronal membranes and synaptic proteins, altering the systems that maintain calcium balance and support neurotransmission. These disturbances can weaken communication between neurons and interfere with synaptic plasticity, the capacity of synapses to change their strength. The resulting dysfunction may appear before widespread plaque formation or extensive neuronal loss.
Soluble oligomers draw attention to early neuronal injury because harmful effects may develop before extensive plaques are present. Their interactions with membranes and synaptic proteins provide a possible route from beta amyloid accumulation to altered calcium homeostasis, impaired neurotransmission, oxidative stress, and inflammatory signaling. This makes oligomer-related changes relevant to early disease mechanisms.
These processes represent connected forms of neuronal stress rather than isolated effects. Disrupted calcium homeostasis can impair neuronal signaling, while oxidative stress and inflammatory signaling add further cellular strain. Together, the changes can compromise synaptic plasticity and contribute to neuronal dysfunction or cell death, helping explain how synaptic injury may progress during neurodegeneration.
Researchers can examine the process in cellular and animal models to evaluate disease mechanisms and the consequences of peptide exposure or accumulation. These models support analysis of synaptic dysfunction, neuronal injury, and related stress responses. Comparing findings across model systems can help connect molecular interactions with broader patterns of neurodegeneration.
Models of beta amyloid toxicity can be used to assess strategies aimed at peptide production, aggregation, or clearance, as well as approaches that limit downstream neuronal injury. Studying these targets helps determine whether reducing beta amyloid burden or interrupting its effects improves neuronal and synaptic outcomes, providing a framework for comparing potential disease-modifying approaches.
Important outcomes include changes in synaptic plasticity, neurotransmission, calcium homeostasis, oxidative stress, inflammatory signaling, neuronal dysfunction, and cell death. Considering these measures together helps distinguish an early synaptic effect from later neuronal injury. In Alzheimer’s disease research, this broader view connects peptide-related molecular events with the progression of neurodegenerative changes.